379 related articles for article (PubMed ID: 31409583)
1. Pathophysiology and management of monoclonal gammopathy of renal significance.
Jain A; Haynes R; Kothari J; Khera A; Soares M; Ramasamy K
Blood Adv; 2019 Aug; 3(15):2409-2423. PubMed ID: 31409583
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].
Smirnov AV; Afanasyev BV; Poddubnaya IV; Dobronravov VA; Khrabrova MS; Zakharova EV; Nikitin EA; Lysenko Kozlovskaya LV; Bobkova IN; Rameev VV; Batyushin MM; Moiseev IS; Darskaya EI; Pirogova OV; Mendeleeva LP; Biryukova LS
Ter Arkh; 2020 Sep; 92(7):10-22. PubMed ID: 33346441
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
6. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
7. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
Sprangers B; Hegenbart U; Wetzels JFM
Transplantation; 2023 May; 107(5):1056-1068. PubMed ID: 36584374
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
[TBL] [Abstract][Full Text] [Related]
10. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
[TBL] [Abstract][Full Text] [Related]
11. How I treat monoclonal gammopathy of renal significance (MGRS).
Fermand JP; Bridoux F; Kyle RA; Kastritis E; Weiss BM; Cook MA; Drayson MT; Dispenzieri A; Leung N;
Blood; 2013 Nov; 122(22):3583-90. PubMed ID: 24108460
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
Ciocchini M; Arbelbide J; Musso CG
Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
[TBL] [Abstract][Full Text] [Related]
14. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine.
Li JP; Du YT; Li S; Rao XR
Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098
[TBL] [Abstract][Full Text] [Related]
17. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy: The good, the bad and the ugly.
Glavey SV; Leung N
Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
[TBL] [Abstract][Full Text] [Related]
19. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
Gomes-Alves I; Castro-Ferreira I
Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
